Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Illinois at Chicago
- Study ID
- NCT07498322
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Opiod Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 16 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- OUD screening — OTHERCompleted screening for opioid use disorder
- MOUD — OTHERMedication treatment for opioid use disorder
- Continuity of care — OTHERFacilitation of outpatient treatment linkages
Study Details
This study, called the Chicago Data-driven Opioid use disorder Screening, Engagement, Treatment and Planning (C-DOSETaP) System, tests a new system of clinical care for patients with opioid use disorder (OUD) across a large health system. The main questions this study aims to answer are: 1. Does the C-DOSETaP System increase screening for patients with OUD; 2. Does the C-DOSETaP System improve continuity of health care for patients with OUD; 3. Does the C-DOSETaP System increase use of medications for opioid use disorder; and 4. Does the C-DOSETaP System reduce the number of opioid-related deaths in the neighborhoods served.
Key Dates
- Start date
- Jun 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2028
- Completion
- Jun 30, 2029
Study Design
- Enrollment
- 271,031 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Patients with OUDPatients with opioid use disorder identified through C-DOSETaP system
Primary Outcome Measure
Number of people screened for OUD [ Time Frame: Rolling measure of annual rates (12 months) measured over the implementation period. ]
Central Contacts
- Niranjan S. Karnik, MD, PhD(312) 273-0185
- Neeraj Chhabra, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Illinois Hospitals and Clinics (UI Health) | Chicago | Illinois | 60608 | Neeraj Chhabra, MD |
Find similar trials in Chicago, IL
Related Studies
- EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive ApplicationsRecruiting · University of Illinois at Chicago · Chicago, Illinois
- Vanderbilt Integrated Community TMS for Opioid RecoveryRecruiting · Vanderbilt University Medical Center · Brentwood, Tennessee